NCT01734733View on ClinicalTrials.gov

Open-label Investigation of the Safety and Clinical Effects of NTCELL in Patients With Parkinson's Disease

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

July 12, 2013

Primary Completion Date

June 4, 2015

Study Completion Date

June 4, 2020

Conditions
Parkinson's Disease
Interventions
OTHER

NTCELL

Trial Locations (1)

Unknown

Auckland City Hospital, Auckland

Sponsors
All Listed Sponsors
lead

Living Cell Technologies

INDUSTRY